ZEAL.CO vs. FXAIX

In the year-to-date period, ZEAL.CO achieves a 0.56% return, which is significantly lower than FXAIX's 3.29% return. Over the past 10 years, ZEAL.CO has outperformed FXAIX with an annualized return of 23.89%, while FXAIX has yielded a comparatively lower 13.07% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Zealand Pharma A/S (ZEAL.CO) and Fidelity 500 Index Fund (FXAIX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current ZEAL.CO Sharpe Ratio is 0.87, which is lower than the FXAIX Sharpe Ratio of 1.80. The chart below compares the historical Sharpe Ratios of ZEAL.CO and FXAIX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

ZEAL.CO has not paid dividends to shareholders, while FXAIX's dividend yield for the trailing twelve months is around 1.21%.

The maximum ZEAL.CO drawdown since its inception was -75.53%, which is greater than FXAIX's maximum drawdown of -33.79%. Use the drawdown chart below to compare losses from any high point for ZEAL.CO and FXAIX. For additional features, visit the drawdowns tool.

Zealand Pharma A/S (ZEAL.CO) has a higher volatility of 12.90% compared to Fidelity 500 Index Fund (FXAIX) at 3.49%. This indicates that ZEAL.CO's price experiences larger fluctuations and is considered to be riskier than FXAIX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.